BPMX - .2089 Pre-market now at .25/.26 BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans BZ: UPDATE: BioPharmX Announces FDA Offered Positive Feedback Related To Design Of Co.'s Planned Phase 3 Trial For BPX-01 http://stockcharts.com/c-sc/sc?s=BPMX&p=D&b=5&g=0&i=t06069465395&r=1510150708422 http://stockcharts.com/c-sc/sc?s=BPMX&p=W&b=5&g=0&i=t08253024131&r=1510150723528